European Archives - Page 911 of 1571 - European Medical Journal

EMJ Gastroenterology 11 [Supplement 6]

The 2022 International Scientific Conference of Probiotics, Prebiotics, Gut Microbiota and Health® took place in Bratislava, Slovakia, from 27th–30th June. A common theme throughout the conference was that, although significant progress has been made, considerable work remains to be done in understanding how probiotics work, aligning definitions of microbiome-modifying agents, and communicating evidence-based recommendations to clinicians and consumers.

A Comparative Study of Local Dietary Intake Among Subjects with Hypertensive Disorders of Pregnancy Attending Antenatal Care

Hypertensive disorders of pregnancy remain among the most significant causes of pregnancy-related complications. The research by the Dietary Approaches to Stop Hypertension (DASH) group revealed that non-pharmacological measures and intervention such as diet can be used to control blood pressure.

Atopic Dermatitis: An Interactive Case

A highly engaging series of questions and exercises about a case of atopic dermatitis in a 10-month-old child patient.

Wound Care: An Interactive Case

A highly engaging series of questions and exercises about wound care, starting from a case of an 83-year-old female patient with rheumatoid arthritis presenting with a toe lesion.

Supporting women with psoriasis: How can behavioural science help us?

This EMJ Podcast, hosted by Gemma Boak, research scientist and health advocate, explores how psychology can be used to optimise the management of treatment for women with psoriasis.

The emergence of digital twins

What is a digital twin and how do they benefit pharma?

Overlapping Clinical Manifestations of Multisystem Inflammatory Syndrome with Other Endemic Diseases

Multisystem inflammatory syndrome (MIS-C) is a challenging disease associated with COVID-19. Clinical manifestation of MIS-C may mimic many endemic illnesses of tropical and subtropical countries, making early diagnosis more difficult.

Going the extra mile for women's health

How can pharma boost R&D efforts into women’s health issues?

The Clock Is Ticking: The Imminent Need to Re-evaluate the Standard of Care in the 90-Day High-Risk Post-Acute Myocardial Infarction Period

The imminent need to re-evaluate the standard of care in the 90-day high-risk post-acute myocardial infarction period.

EMJ Cardiology 10 [Supplement 4] 2022

Speaking at the European Society of Cardiology (ESC) Congress 2021, Gabriel Steg and Kausik Ray discussed the residual risk of recurrent cardiovascular (CV) events that remains despite optimal standards of care for secondary prevention in the 90-day high-risk period after an acute myocardial infarction (AMI).